For many men with prostate cancer, weeks of daily treatments are no longer the norm. Jonathan Tward, MD, a radiation oncologist at Huntsman Cancer Institute, explains how image guidance, real-time ...

Optimal Planning Target Volume for Stage I Testicular Seminoma: A Medical Research Council Randomized Trial PURPOSE: To develop evidence-based guidelines for (1) prostate re-biopsy after radiation and ...

PURPOSE: Radical prostatectomy and external-beam radiation are the most common treatments for localized prostate cancer. Given the absence of clinical consensus in favor of one treatment or the other, ...

A longitudinal study that tracked men over 10 years aims to provide patients with more information about their options following a diagnosis of prostate cancer. The study published Tuesday in the ...

Prostate cancer stands as a significant health concern for men, emphasizing the paramount need for a comprehensive understanding of the available treatment options. Thanks to continuous advancements ...

Receiving radiotherapy after prostatectomy does negatively affect long-term health-related quality of life, including sexual function, urinary incontinence, and urinary irritation, but the timing of ...

NORFOLK, Va. — Hugs and pictures from the wonderful team at Sentara's Radiation-Oncology department on my final session of radiation. It's been five weeks of daily doses. This all follows results from ...

An expert explained the benefits of proton therapy for the treatment of prostate cancer, which delivers radiation directly to the tumor and spares surrounding areas. Proton therapy for the treatment ...

Hypofractionation of radiation therapy in men with high-risk prostate cancer is not associated with worse overall survival or prostate cancer mortality. Survival outcomes are comparable after ...

A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, "Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation ...

Mack Roach, III, MD, FASTRO, has been chosen by the American Society for Radiation Oncology (ASTRO) to receive its 2024 Gold Medal Award. Roach is being recognized with ASTRO’s highest honor for his ...